相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Parents' postnatal depressive symptoms and their children's academic attainment at 16 years: Pathways of risk transmission
Lamprini Psychogiou et al.
BRITISH JOURNAL OF PSYCHOLOGY (2020)
Organising the front line: Is there a rationale for the first-line pharmacotherapy of major depressive disorder?
Bernhard T. Baune et al.
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2019)
Immunoregulatory natural compounds in stress-induced depression: An alternative or an adjunct to conventional antidepressant therapy?
Liliya V. Vasileva et al.
FOOD AND CHEMICAL TOXICOLOGY (2019)
Alzheimer's disease
C. A. Lane et al.
EUROPEAN JOURNAL OF NEUROLOGY (2018)
The role of memantine in the treatment of major depressive disorder: Clinical efficacy and mechanisms of action
Meysam Amidfar et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2018)
Memantine for the Treatment of Dementia: A Review on its Current and Future Applications
Jaume Folch et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
Effect of memantine combination therapy on symptoms in patients with moderate-to-severe depressive disorder: randomized, double-blind, placebo-controlled study
M. Amidfar et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2017)
Advances in antidepressants for treating post-stroke depression
Stefano Paolucci
EXPERT OPINION ON PHARMACOTHERAPY (2017)
A Meta-Analysis of Memantine for Depression
Taro Kishi et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Memantine as an Augmentation Treatment for Schizophrenia: Limitations of Meta-Analysis for Evidence-Based Evaluation of Research
Chittaranjan Andrade
JOURNAL OF CLINICAL PSYCHIATRY (2017)
Inflammation-induced depression: Its pathophysiology and therapeutic implications
Sang Won Jeon et al.
JOURNAL OF NEUROIMMUNOLOGY (2017)
Depression and posttraumatic stress disorder among road traffic accident victims managed in a Tertiary hospital in Southern Nigeria
J. E. Asuquo et al.
NIGERIAN JOURNAL OF CLINICAL PRACTICE (2017)
Memantine add-on to antipsychotic treatment for residual negative and cognitive symptoms of schizophrenia: a meta-analysis
Taro Kishi et al.
PSYCHOPHARMACOLOGY (2017)
Zinc in the Monoaminergic Theory of Depression: Its Relationship to Neural Plasticity
Urszula Doboszewska et al.
NEURAL PLASTICITY (2017)
Effect of co-administration of memantine and sertraline on the antidepressant-like activity and brain-derived neurotrophic factor (BDNF) levels in the rat brain
Meysam Amidfar et al.
BRAIN RESEARCH BULLETIN (2017)
Management of Depression in Patients with Dementia: Is Pharmacological Treatment Justified?
Andrew H. Ford et al.
DRUGS & AGING (2017)
Combined treatment with memantine/es-citalopram for older depressed patients with cognitive impairment: a pilot study
Gregory H. Pelton et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2016)
The Phenomenology of Major Depression and the Representativeness and Nature of DSM Criteria
Kenneth S. Kendler
AMERICAN JOURNAL OF PSYCHIATRY (2016)
Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants
Ronald S. Duman et al.
NATURE MEDICINE (2016)
A two decade dementia incidence comparison from the Cognitive Function and Ageing Studies I and II
F. E. Matthews et al.
NATURE COMMUNICATIONS (2016)
Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders
Gin S. Malhi et al.
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2015)
Alzheimer's Disease Risk Genes and Mechanisms of Disease Pathogenesis
Celeste M. Karch et al.
BIOLOGICAL PSYCHIATRY (2015)
Off-label Use of Memantine as Adjunctive Treatment in Schizophrenia: A Retrospective Case Series Study
J. P. John et al.
PHARMACOPSYCHIATRY (2014)
Schizophrenia or Possession?
M. Kemal Irmak
JOURNAL OF RELIGION & HEALTH (2014)
Schizophrenia or Possession?
M. Kemal Irmak
JOURNAL OF RELIGION & HEALTH (2014)
Antidepressant Augmentation Using the N-Methyl-D-Aspartate Antagonist Memantine: A Randomized, Double-Blind, Placebo-Controlled Trial
Eric G. Smith et al.
JOURNAL OF CLINICAL PSYCHIATRY (2013)
Memantine Add-On to Risperidone for Treatment of Negative Symptoms in Patients With Stable Schizophrenia Randomized, Double-Blind, Placebo-Controlled Study
Farzin Rezaei et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2013)
Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy
Chia-Chan Liu et al.
NATURE REVIEWS NEUROLOGY (2013)
New Insights into the Dementia Epidemic
Eric B. Larson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Making Alzheimer's and dementia research fit for populations
Carol Brayne et al.
LANCET (2012)
Molecular consequences of amyloid precursor protein and presenilin mutations causing autosomal-dominant Alzheimer's disease
Sascha Weggen et al.
ALZHEIMERS RESEARCH & THERAPY (2012)
Neurochemical and behavioural effects of acute and chronic memantine administration in rats: Further support for NMDA as a new pharmacological target for the treatment of depression?
Gislaine Z. Reus et al.
BRAIN RESEARCH BULLETIN (2010)
N-methyl-D-aspartate (NMDA) receptor dysfunction or dysregulation: The final common pathway on the road to schizophrenia?
Joshua T. Kantrowitz et al.
BRAIN RESEARCH BULLETIN (2010)
CHRONIC FLUOXETINE TREATMENT INDUCES STRUCTURAL PLASTICITY AND SELECTIVE CHANGES IN GLUTAMATE RECEPTOR SUBUNITS IN THE RAT CEREBRAL CORTEX
E. Ampuero et al.
NEUROSCIENCE (2010)
Targeting glial physiology and glutamate cycling in the treatment of depression
Gerald W. Valentine et al.
BIOCHEMICAL PHARMACOLOGY (2009)
Emerging role of glutamate in the pathophysiology of major depressive disorder
Kenji Hashimoto
BRAIN RESEARCH REVIEWS (2009)
A Randomized, Placebo-Controlled Study of Memantine as Adjunctive Treatment in Patients with Schizophrenia
Jeffrey A. Lieberman et al.
NEUROPSYCHOPHARMACOLOGY (2009)
Double-blind, randomized comparison of memantine and escitalopram for the treatment of major depressive disorder comorbid with alcohol dependence
Leea H. Muhonen et al.
JOURNAL OF CLINICAL PSYCHIATRY (2008)
The molecular neurobiology of depression
Vaishnav Krishnan et al.
NATURE (2008)
Glutamate and dopamine dysregulation in schizophrenia - A synthesis and selective review
James M. Stone et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2007)
An open-label, flexible-dose study of memantine in major depressive disorder
James M. Ferguson et al.
CLINICAL NEUROPHARMACOLOGY (2007)
A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression
Carlos A. Zarate et al.
ARCHIVES OF GENERAL PSYCHIATRY (2006)
Glutamate and schizophrenia: Beyond the dopamine hypothesis
Joseph T. Coyle
CELLULAR AND MOLECULAR NEUROBIOLOGY (2006)
Catatonic schizophrenia and the use of memantine
SS Carpenter et al.
ANNALS OF PHARMACOTHERAPY (2006)
Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: Implications for clinical practice
MH Trivedi et al.
AMERICAN JOURNAL OF PSYCHIATRY (2006)
A life-course approach to the aetiology of late-onset dementias
LJ Whalley et al.
LANCET NEUROLOGY (2006)
Manic-depressive illness:: Evolution in Kraepelin's textbook, 1883-1926
K Trede et al.
HARVARD REVIEW OF PSYCHIATRY (2005)
Influence of life stress on depression: Moderation by a polymorphism in the 5-HTT gene
A Caspi et al.
SCIENCE (2003)
Depression and bipolar support alliance consensus statement on the unmet needs in diagnosis and treatment of mood disorders in late life
DS Charney et al.
ARCHIVES OF GENERAL PSYCHIATRY (2003)
Altered NMDA glutamate receptor antagonist response in recovering ethanol-dependent patients
JH Krystal et al.
NEUROPSYCHOPHARMACOLOGY (2003)
NMDA receptor pathways as drug targets
JA Kemp et al.
NATURE NEUROSCIENCE (2002)
Medicine - The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics
J Hardy et al.
SCIENCE (2002)
The N-methyl-D-aspartate receptor channel blockers memantine, MRZ 2/579 and other amino-alkyl-cyclohexanes antagonise 5-HT3 receptor currents in cultured HEK-293 and N1E-115 cell systems in a non-competitive manner
G Rammes et al.
NEUROSCIENCE LETTERS (2001)
分享论文
